Grant: Discovery Grants Program - Individual
Université Laval
$48,000.00
Natural Product Synthesis and Development of Synthesis-Enabling Methodologies
FY 2024-25
Summary
The ability to synthesize organic molecules rapidly and efficiently is inextricably linked to the success of R&D efforts and sustained profitability in the pharmaceutical, agrochemical and fine-chemical industries. Natural products have been refined over millions of years for biological interactions, and as such, they represent an unsurpassed source of life-saving drugs and drug leads. However, their limited availability from the natural source can hamper biological assessment. This is particularly common for compounds isolated from unculturable microbes and marine organisms, where recollection is often problematic or impossible. In such cases, chemical synthesis is the only option for supplying the material needed for pharmacological investigation. A practical and flexible synthesis can also serve as a blueprint for generating custom-designed analogues of superior therapeutic performance.
Hence, the prime objective of our research is to develop new methods and strategies enabling rapid and efficient access to natural products of biological importance. Our target molecules include the marine terpenoids niphateolide A (anticancer) and hippolide J (antifungal), which have yet to succumb to chemical synthesis, and fungal butenolides such as aurantricholides A-B that have eluded biological investigation due to their scarcity in nature and inefficiency of their current synthesis (<1% yield). These molecules instill unique synthetic challenges, providing a strong impetus to invent new methodologies and expand upon the discoveries and creative contributions of my talented co-workers. The goal is to achieve maximum increase in target-relevant complexity while minimizing step count, cost and chemical waste. One way of accomplishing this is through strategic implementation of reaction cascades and one-pot procedures. Reaction cascades allow two or more bond-forming transformations to be performed under the same conditions sequentially without the need for work-up and product isolation between successive synthesis steps. Besides improving efficiency, this approach makes the synthesis substantially greener as it reduces the amount of solvents used in the synthesis, work-up and product isolation, and contaminated aqueous waste generated from cleaning equipment and glassware.
The proposed research will have application in the synthesis of a variety of other biologically important natural products and small molecules. Collaborations are in place to evaluate the synthesized compounds as antimicrobial, anticancer and herbicidal agents. In the long term, this research may have an impact on the discovery of new healing drugs and agrochemicals.
The target oriented nature of the work ensures that students will acquire broad-based training in organic synthesis and invaluable problem-solving skills. Such skills and expertise are of paramount importance to the rapidly growing pharmaceutical industry in Canada.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2020-05909
Name nom
Boukouvalas, John
Department département
Chimie - Chimie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
48000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Natural Product Synthesis and Development of Synthesis-Enabling Methodologies
Keywords
total synthesis; asymmetric synthesis; biomimetic synthesis; butenolides; terpenoids; cascade reactions; green and sustainable chemistry; oxyfunctionalization; carbonyl-olefin metathesis; photochemistry
Application summary
The ability to synthesize organic molecules rapidly and efficiently is inextricably linked to the success of R&D efforts and sustained profitability in the pharmaceutical, agrochemical and fine-chemical industries. Natural products have been refined over millions of years for biological interactions, and as such, they represent an unsurpassed source of life-saving drugs and drug leads. However, their limited availability from the natural source can hamper biological assessment. This is particularly common for compounds isolated from unculturable microbes and marine organisms, where recollection is often problematic or impossible. In such cases, chemical synthesis is the only option for supplying the material needed for pharmacological investigation. A practical and flexible synthesis can also serve as a blueprint for generating custom-designed analogues of superior therapeutic performance.
Hence, the prime objective of our research is to develop new methods and strategies enabling rapid and efficient access to natural products of biological importance. Our target molecules include the marine terpenoids niphateolide A (anticancer) and hippolide J (antifungal), which have yet to succumb to chemical synthesis, and fungal butenolides such as aurantricholides A-B that have eluded biological investigation due to their scarcity in nature and inefficiency of their current synthesis (<1% yield). These molecules instill unique synthetic challenges, providing a strong impetus to invent new methodologies and expand upon the discoveries and creative contributions of my talented co-workers. The goal is to achieve maximum increase in target-relevant complexity while minimizing step count, cost and chemical waste. One way of accomplishing this is through strategic implementation of reaction cascades and one-pot procedures. Reaction cascades allow two or more bond-forming transformations to be performed under the same conditions sequentially without the need for work-up and product isolation between successive synthesis steps. Besides improving efficiency, this approach makes the synthesis substantially greener as it reduces the amount of solvents used in the synthesis, work-up and product isolation, and contaminated aqueous waste generated from cleaning equipment and glassware.
The proposed research will have application in the synthesis of a variety of other biologically important natural products and small molecules. Collaborations are in place to evaluate the synthesized compounds as antimicrobial, anticancer and herbicidal agents. In the long term, this research may have an impact on the discovery of new healing drugs and agrochemicals.
The target oriented nature of the work ensures that students will acquire broad-based training in organic synthesis and invaluable problem-solving skills. Such skills and expertise are of paramount importance to the rapidly growing pharmaceutical industry in Canada.